Company Profile

H G Pars Pharmaceutical Labs Inc (AKA: Sisa Pharmaceuticals)
Profile last edited on: 6/4/14      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

9 Hancock Street
Lexington, MA 02420
   (781) 863-8390
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

Originally doing business as Sisa Pharmaceuticals in Cambridge, MA, the firm was an awardee in the original NSF and DOD programs (called DESAT) which formed the basis on which the federal SBIR program was initiated. Harry Pars, founding president, had previously worked at Arthur D Little. He was actively involved in the projects out SBANE - Smaller Business Assoiation of New England - which launched the initaive to make SBIR government wide. He used a familial connection to the then Speaker of the house - Tip O'Neil - to get the enabling legislation onto the floor of the House where it had been stalled by the energetic opposition through a process of sequential referrals in seven House Committees. The Senate had already approved the program by an almost unanimous vote. After the Speaker's order to release the bill, the highly conscientious debate in the House lasted several hours and involved several votes - the first of which passed by the narrowest of margins. The tide then turned and each vote was more in favor than the last with many Members subsequently chnaging their vote when passage of the law was eventually assured.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1985 1 NIH $45,000
Project Title: Water-Soluble Derivatives of Gossypol
1985 2 NIH $623,455
Project Title: Benzopyranopyridines as novel analagesic agents
1985 1 NIH $50,000
Project Title: New-B Lactam antibiotics: Oxacephalosporin analogs
1985 1 NIH $50,000
Project Title: Bacteriocides & fungicides for health care
1985 1 NIH $50,000
Project Title: Cannabinoids as antihypertensive agents

Key People / Management

  Harry G Pars -- President

  Paul Blundell

  Paul Blundell

  Eric Duffy

  Ellen M Essigmann

  Paul Meltzer

Company News

There are no news available.